POLE and neoplasm: Women with p53abn tumours had significantly improved survival rates when treated with adjuvant chemo-radiation therapy, whilst women with POLE-mutated EC had incredibly good prognoses regardless of treatment arm (chemotherapy or chemo-radiation therapy).